Don't have a TCI SuperCoder account yet? Become a Member >>

Oncology & Hematology Coding Alert

Indications, Formulations, Dosage and Administration of Pembrolizumab and Ramucirumab

Pembrolizumab Indications: Pembrolizumab is used in metastatic NSCLC that expresses PD-L1 and whose disease progressed with or following platinum-containing chemotherapy. It is also used in lung cancer that has an abnormal “EGFR” or “ALK” gene and has not responded to EGFR or ALK inhibitors medications. Another indication for pembrolizumab is advanced melanoma no longer good for surgical excision and not [...]


Other Articles in this issue of

Oncology & Hematology Coding Alert

View All